Protea Fund - Sectoral Biotech Opportunities Fund Class IF H Fonds
7,90
CHF
+0,06
CHF
+0,77
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Amgen Inc | US0311621009 | 8,27% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 8,18% |
| Gilead Sciences Inc | US3755581036 | 7,75% |
| AstraZeneca PLC ADR | US0463531089 | 4,90% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 4,87% |
| argenx SE ADR | US04016X1019 | 3,95% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 3,59% |
| Insmed Inc | US4576693075 | 2,66% |
| BeOne Medicines Ltd ADR | US07725L1026 | 2,58% |
| Blueprint Medicines Corp | US09627Y1091 | 2,55% |
| Sonstige | 50,70% |